AMG-305
- Generic Name
- AMG-305
Study to Explore the Safety, Tolerability, and Pharmacokinetics of AMG 305 in Subjects With Advanced Solid Tumors
- First Posted Date
- 2023-04-06
- Last Posted Date
- 2025-05-08
- Lead Sponsor
- Amgen
- Target Recruit Count
- 220
- Registration Number
- NCT05800964
- Locations
- 🇩🇪
Universitaetsklinikum Essen, Essen, Germany
🇬🇧Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom
🇺🇸City of Hope National Medical Center, Duarte, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath